Summit Therapeutics (SMMT)
(Delayed Data from NSDQ)
$29.13 USD
-0.19 (-0.65%)
Updated Aug 5, 2025 04:00 PM ET
After-Market: $29.12 -0.01 (-0.03%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth F Momentum F VGM
Fundamental Charts
About Dividend Yield (TTM)
Summit Therapeutics PLC's dividend yield currently sits at 0%, which is in-line with the Medical - Drugs industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
SMMT 29.13 -0.19(-0.65%)
Will SMMT be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for SMMT based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for SMMT
Merck Q2 Earnings in the Cards: Buy, Sell or Hold Ahead of Results?
Elevance to Report Q2 Earnings: Will Rising Costs Pressure Profits?
SMMT: What are Zacks experts saying now?
Zacks Private Portfolio Services
Merck's VRNA Buyout to Add Novel COPD Therapy: How to Play the Stock?
SMMT Stock Gains on Rumored Licensing Talks With AstraZeneca
Wall Street Analysts Believe Summit Therapeutics (SMMT) Could Rally 63.02%: Here's is How to Trade
Other News for SMMT
Commit To Buy Summit Therapeutics At $18, Earn 30.8% Annualized Using Options
Summit Therapeutics: Not Entirely Positive HARMONi Data And Partnership Rumors
10 Health Care Stocks Whale Activity In Today's Session
Johnson & Johnson Raises FY25 Forecast, Joins Rigetti Computing, Unity Software, Brighthouse Financial And Other Big Stocks Moving Higher On Wednesday
Notable Wednesday Option Activity: SMMT, PEP, ZM